Inflammation: a unifying theory for the origin of dry eye syndrome.
Dry eye syndrome has been difficult to diagnose and treat, due to its heterogeneity. These difficulties are being overcome, however, as evidence becomes available about a common etiology. An inflammatory mechanism apparently underlies the condition. This theory has been proven by use of immunomodulators that show efficacy in treating patients with dry eye syndrome.
Wilson
Steven E
SE
Cole Eye Institute, Cleveland Clinic Foundation, USA.
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D016572:Cyclosporine / Q000008:administration & dosage; D006801:Humans; D007249:Inflammation / Q000276:immunology; D007638:Keratoconjunctivitis Sicca / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D007765:Lacrimal Apparatus / Q000503:physiopathology; D008875:Middle Aged; D013666:Tears / Q000378:metabolism; D014481:United States
D000893:Anti-Inflammatory Agents; D016572:Cyclosporine